Previous Close | 4.890 |
Open | 4.890 |
Bid | 4.950 x N/A |
Ask | 5.000 x N/A |
Day's Range | 4.820 - 5.150 |
52 Week Range | 3.540 - 7.570 |
Volume | |
Avg. Volume | 1,442,151 |
Market Cap | 5.948B |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | 6.67 |
EPS (TTM) | 0.750 |
Earnings Date | Aug 22, 2024 - Aug 26, 2024 |
Forward Dividend & Yield | 0.10 (2.04%) |
Ex-Dividend Date | Jul 03, 2024 |
1y Target Est | 8.35 |
The World Bank recently released its updated "Global Economic Outlook" report, projecting a 2.1% global economic growth for 2023. This forecast represents an upward revision of 0.4 percentage points compared to the previous prediction in January, yet it still falls short of the 3.1% growth anticipated for 2022. At present, the global economy remains in a recovery phase, and businesses continue to confront a multitude of risks. In the post-pandemic era, it becomes particularly essential for compa
June 26th, 2023, Pharmadule Morimatsu and WuXi Biologics officially entered into a global strategic cooperation for the Singapore CRDMO Center project of WuXi Biologics.